Case report: Skin discoloration following administration of colloidal silver in cystic fibrosis

Current Opinion in Pediatrics

Volumn 19, Issue 6, 2007, Pages 733-735

  Baker, Christopher D ^a   Federico, Monica J ^a   Accurso, Frank J ^a  

^a CHILDREN S HOSPITAL   (United States)

Author keywords

Argyria; Colloidal silver; Complementary and alternative medicine; Cystic fibrosis; Silver colloid; Silver toxicity

Indexed keywords

CIPROFLOXACIN; SILVER; TOBRAMYCIN;

ALTERNATIVE MEDICINE; ARGYRIA; AUSCULTATION; BODY MASS; CASE REPORT; CLUBBING FINGERS; COUGHING; CYSTIC FIBROSIS; ELECTRODE; GENETIC POLYMORPHISM; GENOTYPE; HAEMOPHILUS INFLUENZAE; HEALTH HAZARD; HUMAN; LUNG CLEARANCE; MALE; PATIENT CARE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SCHOOL CHILD; SKIN DISCOLORATION; SPIROMETRY; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

ARGYRIA; CHILD; COLLOIDS; COMPLEMENTARY THERAPIES; CYSTIC FIBROSIS; HUMANS; MALE; SILVER; SKIN PIGMENTATION;

EID: 36349029134     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3282f11fee     Document Type: Review

References (26)

1. Rowe SM, Clancy JP. Advances in cystic fibrosis therapies. Curr Opin Pediatr 2006; 18:604-613.
2. Cystic Fibrosis Foundation National Patient Registry Annual Data Report 2005. Bethesda, MD: Cystic Fibrosis Foundation; 2005.
3. Accurso FJ. Update in cystic fibrosis 2005. Am J Respir Crit Care Med 2006; 173:944-947.
4. Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis [Review]. Cochrane Database Syst Rev 2000(2): CD001289.
5. Donaldson SH, Bennett WD, Zeman KL, et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006; 354:241-250.
6. Stern RC, Canda ER, Doershuk CF. Use of nonmedical treatment by cystic fibrosis patients. J Adolesc Health 1992; 13:612-615.
7. Glasscoe CA, Quittner AL. Psychological interventions for cystic fibrosis [Review]. Cochrane Database Syst Rev 2005(3): CD003148.
8. Hernandez-Reif M, Field T, Krasnego J, et al. Children with cystic fibrosis benefit from massage therapy. J Pediatr Psychol 1999; 24:175-181.
9. Grasso MC, Button BM, Allison DJ, Sawyer SM. Benefits of music therapy as an adjunct to chest physiotherapy in infants and toddlers with cystic fibrosis. Pediatr Pulmonol 2000; 29:371-381.
10. Anbar RD. Self-hypnosis for patients with cystic fibrosis. Pediatr Pulmonol 2000; 30:461-465.
11. Goodill SW. Dance/movement therapy for adults with cystic fibrosis: pilot data on mood and adherence. Altern Ther Health Med 2005; 11:76-77.
12. Lin YC, Ly H, Golianu B. Acupuncture pain management for children with cystic fibrosis: a pilot study. Am J Chin Med 2005; 33:151-156.
13. Samdup DZ, Smith RG, Song SI. The use of complementary and alternative medicine in children with chronic medical conditions. Am J Phys Med Rehabil 2006; 85:842-846.
14. Martel D, Bussieres J-F, Theoret Y, et al. Use of alternative and complementary therapies in children with cancer. Pediatr Blood Cancer 2005; 44:1-9.
15. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
16. Anonymous. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Fed Regist 1999; 64:44653-44658.
17. Van Haselt P, Gashe BA, Ahmad J. Colloidal silver as an antimicrobial agent: fact or fiction? J Wound Care 2004; 13:154-155.
18. Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment [Review]. J Toxicol Clin Toxicol 1996; 34:119-126.
19. Fung MC, Weintraub M, Bowen DL. Colloidal silver proteins marketed as health supplements [Letter]. JAMA 1995; 274:1196-1197.
20. Brandt D, Park B, Hoang M, Jacobe HT. Argyria secondary to ingestion of homemade silver solution. J Am Acad Dermatol 2005; 53:S105-S107.
21. Gulbranson SH, Hud JA, Hansen RC. Argyria following the use of dietary supplements containing colloidal silver protein. Cutis 2000; 66:373-374.
22. White JML, Powell AM, Brady K, Russell-Jones R. Severe generalized argyria secondary to ingestion of colloidal silver protein. Clin Exp Dermatol 2003; 28:254-256.
23. Mirsattari SM, Hammond RR, Sharpe MD, et al. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 2004; 62:1408-1410.
24. Ferguson J, Dawe R. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin. J Antimicrob Chemother 1997; 40 (suppl. A):93-98.
25. Cohen MH, Kemper KJ. Complementary therapies in pediatrics: a legal perspective. Pediatrics 2005; 115:774-780.
26. Eisenberg DM. Advising patients who seek alternative medical therapies. Ann Intern Med 1997; 127:61-69.